224
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Integration Challenges and Opportunity of Implementing Non-Communicable Disease Screening Intervention with Tuberculosis Patient Care: A Mixed Implementation Study

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 2609-2633 | Received 25 Aug 2023, Accepted 18 Nov 2023, Published online: 28 Nov 2023

References

  • World Health Organization. WHO Consolidated Guidelines on Tuberculosis: Tuberculosis Preventive Treatment. World Health Organization; 2020.
  • ABABA A. Federal Democratic Republic of Ethiopia Ministry of Health CLTSH Verification and Certification Protocol; 2012.
  • Organization WH, Staff WHO. Global Tuberculosis Report 2013. World Health Organization; 2013.
  • Wang Y, Wang J. Modelling and prediction of global non-communicable diseases. BMC Public Health. 2020;20(1):1–13. doi:10.1186/s12889-020-08890-4
  • Penaloza R, Navarro JI, Jolly PE, Junkins A, Seas C, Otero L. Health literacy and knowledge related to tuberculosis among outpatients at a referral hospital in Lima, Peru. Res Rep Tropical Med. 2019;1–10. doi:10.2147/RRTM.S189201
  • Tilahun D, Abera A, Nemera G. Communicative health literacy in patients with non-communicable diseases in Ethiopia: a cross-sectional study. Trop Med Health. 2021;49(1):1–9. doi:10.1186/s41182-021-00345-9
  • Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101(4):654–662. doi:10.2105/AJPH.2010.199505
  • Marmot M, Bell R. Social determinants and non-communicable diseases: time for integrated action. BMJ. 2019;364. doi:10.1136/bmj.l251
  • Marais BJ, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infect Dis. 2013;13(5):436–448. doi:10.1016/S1473-3099(13)70015-X
  • Begum N, Nawshin I, Rahman MA. Behavioural Risk Factors of Non-Communicable Diseases among Rural Population in a Selected Area of Dhaka City. J Curr Adv Med Res. 2022;9(1):9–15. doi:10.3329/jcamr.v9i1.59738
  • Organization WH. Noncommunicable Diseases Country Profiles 2018; 2018.
  • Esmailnasab N, Moradi G, Delaveri A. Risk factors of non-communicable diseases and metabolic syndrome. Iran J Public Health. 2012;41(7):77.
  • Organization WH. Global Tuberculosis Report 2020: Executive Summary; 2020.
  • Puchner KP, Rodriguez-Fernandez R, Oliver M, Solomos Z. Non-communicable diseases and tuberculosis: anticipating the impending global storm. Global Public Health. 2019;14(9):1372–1381. doi:10.1080/17441692.2019.1580760
  • Anand T, Kishore J, Isaakidis P, et al. Integrating screening for non-communicable diseases and their risk factors in routine tuberculosis care in Delhi, India: a mixed-methods study. PLoS One. 2018;13(8):e0202256. doi:10.1371/journal.pone.0202256
  • Chen Q, Che Y, Xiao Y, et al. Impact of Multimorbidity Subgroups on the Health Care Use and Clinical Outcomes of Patients With Tuberculosis: a Population-Based Cohort Analysis. Front Public Health. 2021;9. doi:10.3389/fpubh.2021.756717
  • Peltzer K. Tuberculosis non-communicable disease comorbidity and multimorbidity in public primary care patients in South Africa. Af J Primary Health Care Family Med. 2018;10(1):1–6. doi:10.4102/phcfm.v10i1.1651
  • Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of diabetes mellitus among tuberculosis patients in South-Eastern Amhara Region, Ethiopia: a cross sectional study. PLoS One. 2016;11(1):e0147621. doi:10.1371/journal.pone.0147621
  • Govindasamy D, Kranzer K, van Schaik N, et al. Linkage to HIV, TB and non-communicable disease care from a mobile testing unit in Cape Town, South Africa. PLoS One. 2013;8(11):e80017. doi:10.1371/journal.pone.0080017
  • McIntosh J, Alonso A, Codina C, MacLure K, Mair A, Stewart D. Polypharmacy and Integrated Care: identifying synergies in implementation. Int J Integrated Care. 2017;17:1–2.
  • Fuller J, Koehne K, Verrall CC, Szabo N, Bollen C, Parker S. Building chronic disease management capacity in General Practice: the South Australian GP Plus Practice Nurse Initiative. J Royal Coll Nursing Australia. 2015;22(2):191–197. doi:10.1016/j.colegn.2014.02.002
  • Schmidt B, Campbell S, McDermott R. Community health workers as chronic care coordinators: evaluation of an Australian Indigenous primary health care program. Australian N Zealand J Public Health. 2016;40 Suppl 1:S107–S114.
  • Petersen I, van Rensburg A, Kigozi F, et al. Scaling up integrated primary mental health in six low- and middle-income countries: obstacles, synergies and implications for systems reform. BJPsych Open. 2019;5(5):e69. doi:10.1192/bjo.2019.7
  • Al-Alawi K, Al Mandhari A, Johansson H. Care providers’ perceptions towards challenges and opportunities for service improvement at diabetes management clinics in public primary health care in Muscat, Oman: a qualitative study. BMC Health Serv Res. 2019;19(1):18. doi:10.1186/s12913-019-3866-y
  • Cronin J, Murphy A, Savage E. Can chronic disease be managed through integrated care cost-effectively? Evidence from a systematic review. Irish J Med Sci. 2017;186(4):827–834. doi:10.1007/s11845-017-1600-5
  • Hyle EP, Naidoo K, Su AE, El-Sadr WM, Freedberg KA. HIV, tuberculosis, and non-communicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care? J Acquired Immune Deficiency Syndromes. 2014;67(1):S87. doi:10.1097/QAI.0000000000000254
  • Zou G, Zhang W, King R, et al. Process Evaluation of a Clustered Randomized Control Trial of a Comprehensive Intervention to Reduce the Risk of Cardiovascular Events in Primary Health Care in Rural China. Int J Environ Res Public Health. 2020;17(11):4156. doi:10.3390/ijerph17114156
  • Witter S, Zou G, Diaconu K, et al. Opportunities and challenges for delivering non-communicable disease management and services in fragile and post-conflict settings: perceptions of policy-makers and health providers in Sierra Leone. Confl Health. 2020;14:3. doi:10.1186/s13031-019-0248-3
  • Duffy M, Ojikutu B, Andrian S, Sohng E, Minior T, Hirschhorn LR. Non-communicable diseases and HIV care and treatment: models of integrated service delivery. Tropical Medicine and International Health. 2017;22(8):926–937. doi:10.1111/tmi.12901
  • Lupafya PC, Mwagomba BL, Hosig K, Maseko LM, Chimbali H. Implementation of Policies and Strategies for Control of Noncommunicable Diseases in Malawi: challenges and Opportunities. Health Educ Behav. 2016;43(1 Suppl):64S–69S. doi:10.1177/1090198115614313
  • Montenegro H, Holder R, Ramagem C, et al. Combating health care fragmentation through integrated health service delivery networks in the Americas: lessons learned. J Integrated Care. 2011;19(5):5–16. doi:10.1108/14769011111176707
  • Purtle J, Peters R, Brownson RC. A review of policy dissemination and implementation research funded by the National Institutes of Health, 2007–2014. Implementation Sci. 2015;11(1):1–8. doi:10.1186/s13012-015-0367-1
  • Amarchand R, Krishnan A, Saraf DS, Mathur P, Shukla DK, Nath LM. Lessons for addressing noncommunicable diseases within a primary health-care system from the Ballabgarh project, India. WHO South-East Asia j Public Health. 2015;4(2):130–137. doi:10.4103/2224-3151.206682
  • Misra A, Chowbey P, Makkar B, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. Japi. 2009;57(2):163–170.
  • Tabak RG, Khoong EC, Chambers DA, Brownson RC. Bridging research and practice: models for dissemination and implementation research. Am j Preventive Med. 2012;43(3):337–350. doi:10.1016/j.amepre.2012.05.024
  • Reddy KS. Global Burden of Disease Study 2015 provides GPS for global health 2030. Lancet. 2016;388(10053):1448–1449. doi:10.1016/S0140-6736(16)31743-3
  • Dayspring T, Toh S-A, Sellers LA. National Cholesterol Education Program Adult Treatment Panel III NCEP ATP III. Final Rep Circulation. 2004;110(10):1219–1225. doi:10.1161/01.CIR.0000140676.88412.CF
  • Shah B, Mathur P. Surveillance of cardiovascular disease risk factors in India: the need & scope. Indian J Med Res. 2010;132(5):634. doi:10.4103/0971-5916.73420
  • Sharma U, Kishore J, Garg A, Anand T, Chakraborty M, Lali P. Dyslipidemia and associated risk factors in a resettlement colony of Delhi. J Clin Lipidol. 2013;7(6):653–660. doi:10.1016/j.jacl.2013.06.003
  • James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520. doi:10.1001/jama.2013.284427
  • Asturiningtyas IP, Mulyantoro DK, Kusrini I, Ashar H. Non-communicable disease comorbidity and multimorbidity among people with tuberculosis in Indonesia. Ann Tropical Med Public Health. 2021;24(01). doi:10.36295/ASRO.2021.24191
  • White LV, Edwards T, Lee N, et al. Patterns and predictors of co-morbidities in tuberculosis: a cross-sectional study in the Philippines. Sci Rep. 2020;10(1):1–12. doi:10.1038/s41598-020-60942-2
  • Ogbera AO, Kapur A, Abdur-Razzaq H, et al. Clinical profile of diabetes mellitus in tuberculosis. BMJ Open Diabetes Res Care. 2015;3(1):e000112. doi:10.1136/bmjdrc-2015-000112
  • Segafredo G, Kapur A, Robbiati C, et al. Integrating TB and non-communicable diseases services: pilot experience of screening for diabetes and hypertension in patients with Tuberculosis in Luanda, Angola. PLoS One. 2019;14(7):e0218052. doi:10.1371/journal.pone.0218052
  • Pires JE, Sebastião YV, Langa AJ, Nery SV. Hypertension in Northern Angola: prevalence, associated factors, awareness, treatment and control. BMC Public Health. 2013;13(1):1–10. doi:10.1186/1471-2458-13-90
  • Kia NS, Zavareh MN, Sarkheil E, Ghods E. Prevalence of biologic, behavioral and psychosocial determinant of tuberculosis in tuberculosis patients of Semnan city; a five-year cross-sectional study. J Preventive Epidemiol. 2020;5(2):e24–e24. doi:10.34172/jpe.2020.24
  • Poudyal IP, Khanal P, Mishra SR, et al. Cardiometabolic risk factors among patients with tuberculosis attending tuberculosis treatment centers in Nepal. BMC Public Health. 2020;20(1):1–9. doi:10.1186/s12889-020-09472-0
  • Mpagama S, Heysell S, Ndusilo N, Kumburu H, Lekule I. Diagnosis and Interim Treatment Outcomes from the First Cohort of multidrug-resistant tuberculosis patients in Tanzania. PloS one. 2013.
  • Naidoo P, Van Niekerk M, Du Toit E, Beyers N, Leon N. Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests. BMC Health Services Res. 2015;15(1):1–13. doi:10.1186/s12913-015-1145-0
  • Bieh KL, Weigel R, Smith H. Hospitalized care for MDR-TB in Port Harcourt, Nigeria: a qualitative study. BMC Infect Dis. 2017;17(1):1–9. doi:10.1186/s12879-016-2114-x
  • Jacobson KR, Barnard M, Kleinman MB, et al. Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study. Clin Infect Dis. 2017;64(11):1502–1508. doi:10.1093/cid/cix128
  • Doulla BE, Squire SB, MacPherson E, Ngadaya ES, Mutayoba BK, Langley I. Routine surveillance for the identification of drug resistant tuberculosis in Tanzania: a cross-sectional study of stakeholders’ perceptions. PLoS One. 2019;14(2):e0212421. doi:10.1371/journal.pone.0212421
  • Timire C, Sandy C, Kumar AM, et al. Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain® Line Probe Assay in Southern provinces, Zimbabwe. Int J Infect Dis. 2019;81:236–243. doi:10.1016/j.ijid.2019.02.007
  • Oga-Omenka C, Zarowsky C, Agbaje A, Kuye J, Menzies D. Rates and timeliness of treatment initiation among drug-resistant tuberculosis patients in Nigeria-A retrospective cohort study. PLoS One. 2019;14(4):e0215542. doi:10.1371/journal.pone.0215542
  • Mohr E, Daniels J, Muller O, et al. Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF. Int J Tuberculosis Lung Dis. 2017;21(10):1100–1105. doi:10.5588/ijtld.17.0372
  • McLaren ZM, Sharp AR, Zhou J, Wasserman S, Nanoo A. Assessing healthcare quality using routine data: evaluating the performance of the national tuberculosis programme in South Africa. Tropical Medicine and International Health. 2017;22(2):171–179. doi:10.1111/tmi.12819
  • Ebonwu JI, Tint K-S, Ihekweazu C. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011. Int j Tuberculosis Lung Dis. 2013;17(8):1043–1048. doi:10.5588/ijtld.13.0071
  • Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE. Correction: the Impact of Expanded Testing for Multidrug Resistant Tuberculosis Using Geontype MTBDRplus in South Africa: an Observational Cohort Study. PLoS One. 2013;8(6). doi:10.1371/annotation/47420ec0-db00-4994-a0de-86b5e5d713f4
  • Workneh MH, Bjune GA, Yimer SA. Assessment of health system challenges and opportunities for possible integration of diabetes mellitus and tuberculosis services in South-Eastern Amhara Region, Ethiopia: a qualitative study. BMC Health Services Res. 2016;16(1):1–11. doi:10.1186/s12913-016-1378-6
  • Lenka SR, George B. Integrated health service delivery: why and how? National J Med Res. 2013;3(03):297–299.
  • Adamchak S, Janowitz B, Liku J, Munyambanza E, Grey T, Keyes E. Study of Family Planning and HIV Integrated Services in Five Countries. NC, USA: Family Health International, Research Triangle Park; 2010.
  • Lin Y, Li L, Mi F, et al. Screening patients with diabetes mellitus for tuberculosis in China. Tropical Medicine and International Health. 2012;17(10):1302–1308. doi:10.1111/j.1365-3156.2012.03069.x
  • Kumpatla S, Sekar A, Achanta S, et al. Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in South India. Public Health Action. 2013;3(1):23–28. doi:10.5588/pha.13.0035
  • Alemu S, Watkins P. Access to diabetes care in northern Ethiopia. Diabetes Voice. 2004;49(1):8–10.
  • Feleke Y, Enquselassie F. An assessment of the health care system for diabetes in Addis Ababa, Ethiopia. Ethiopian j Health Dev. 2005;19(3):203–210.
  • Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011;11(1):1–12. doi:10.1186/1471-2458-11-564
  • Sullivan T, Ben Amor Y. The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world. PLoS Med. 2012;9(7):e1001269. doi:10.1371/journal.pmed.1001269
  • Kiflie Y, Jira C, Nigussie D. The quality of care provided to patients with chronic non-communicable diseases: a retrospective multi-setup study in Jimma zone, southwest Ethiopia. Ethiopian j Health Sci. 2011;21(2):119–130. doi:10.4314/ejhs.v21i2.69052
  • Idemyor V. Diabetes in sub-Saharan Africa: health care perspectives, challenges, and the economic burden of disease. J National MedAssoc. 2010;102(7):650–653. doi:10.1016/S0027-9684(15)30643-X